Science & Technology
Validation of APT101 for the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) in an Aging Murine Model
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R41AG090138-01A1
Award Ceiling
$292K
Award Floor
$292K
Close Date
May 31, 2027
442 days leftTotal Funding
$292K
Expected Awards
1
Posted Date
Sep 20, 2025
Cost Sharing Required
No
Grants.gov ID
sbir-1R41AG090138-01A1
Description
STTR Phase Phase I award: "Validation of APT101 for the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) in an Aging Murine Model" awarded to ARTIAM BIO INC. in Cary, North Carolina. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $292,279. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.